NASDAQ:IPX IperionX (IPX) Stock Price, News & Analysis $22.94 -0.32 (-1.38%) Closing price 07/17/2026 04:00 PM EasternExtended Trading$23.29 +0.35 (+1.53%) As of 07/17/2026 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About IperionX Stock (NASDAQ:IPX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IperionX alerts:Sign Up Key Stats Today's Range$22.10▼$23.3550-Day Range$22.94▼$44.5752-Week Range$21.66▼$61.45Volume204,322 shsAverage Volume303,007 shsMarket Capitalization$778.58 millionP/E RatioN/ADividend YieldN/APrice Target$60.33Consensus RatingModerate Buy Company Overview IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets. At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights. IperionX is advancing this asset through resource definition and pilot‐scale processing, targeting the recovery of titanium and zirconium minerals for further refinement. By integrating upstream mining with downstream processing, the company seeks to establish a vertically integrated supply chain for strategic metals. IperionX has developed a patented chlorination and reduction process designed to convert mineral feedstocks into titanium sponge and high‐quality titanium powders. These materials are intended to meet the stringent purity and performance standards of aerospace and additive manufacturing applications. The company is also exploring opportunities to expand its technology offering through strategic partnerships and offtake agreements with end‐users. Originally established as Hyperion Metals, IperionX completed its transition to the IperionX name following a corporate rebranding and listing on the NASDAQ in 2022. The company’s leadership team brings experience in mineral processing, metallurgy and advanced materials commercialization. IperionX serves markets in North America with plans to expand its global footprint as its flagship projects move toward commercial production. AI Generated. May Contain Errors. Read More IperionX Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreIPX MarketRank™: IperionX scored higher than 87% of companies evaluated by MarketBeat, and ranked 48th out of 173 stocks in the industrials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingModerate Buy Consensus RatingIperionX has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 5 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialIperionX has a consensus price target of $60.33, representing about 163.0% upside from its current price of $22.94.Amount of Analyst CoverageIperionX has only been the subject of 4 research reports in the past 90 days.Read more about IperionX's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for IperionX are expected to grow in the coming year, from ($0.18) to ($0.04) per share.Price to Book Value per Share RatioIperionX has a P/B Ratio of 7.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about IperionX's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.25% of the float of IperionX has been sold short.Short Interest Ratio / Days to CoverIperionX has a short interest ratio ("days to cover") of 1.85, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IperionX has recently increased by 8.83%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIperionX does not currently pay a dividend.Dividend GrowthIperionX does not have a long track record of dividend growth. News and Social Media4.0 / 5News Sentiment1.42 News SentimentIperionX has a news sentiment score of 1.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Industrials companies.News Coverage This WeekMarketBeat has tracked 11 news articles for IperionX this week, compared to 3 articles on an average week.Search InterestOnly 3 people have searched for IPX on MarketBeat in the last 30 days. This is a decrease of -79% compared to the previous 30 days.MarketBeat Follows4 people have added IperionX to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership3.6 / 5Insider TradingAcquiring Shares Cluster Insider Buying2 insiders have purchased shares of IperionX in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $4,950,618.00 in company stock, which represents 0.6358% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, IperionX insiders have bought more of their company's stock than they have sold. Specifically, they have bought $4,950,618.00 in company stock and sold $0.00 in company stock.Percentage Held by Institutions2.76% of the stock of IperionX is held by institutions.Read more about IperionX's insider trading history. Receive IPX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IperionX and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IPX Stock News HeadlinesIperionX (NASDAQ:IPX) CEO Anastasios Arima Buys 138,720 SharesJuly 14, 2026 | americanbankingnews.comIperionX (NASDAQ:IPX) Chairman Todd Hannigan Purchases 225,000 SharesJuly 14, 2026 | americanbankingnews.comYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answer to a multi-variable problem. Withdrawal sequencing, sequence-of-returns risk, Roth conversion timing, and legacy goals can all shift your real number significantly. Research from Vanguard suggests advisor best practices - covering allocation, rebalancing, tax management, and behavioral coaching - may add roughly 3% in net annual return potential. Morningstar's 2025 data shows the average investor return gap is 1.2% per year due to mistimed buying and selling. Get matched with a fiduciary advisor in your area at no cost and with no obligation to hire.July 18 at 1:00 AM | SmartAsset (Ad)IperionX (NASDAQ:IPX) Chairman Todd Hannigan Acquires 300,000 Shares of StockJuly 14, 2026 | americanbankingnews.comInsider Buying: IperionX (NASDAQ:IPX) CEO Acquires $496,617.60 in StockJuly 14, 2026 | insidertrades.comIperionX Stock Short Interest Report | NASDAQ:IPX | BenzingaJuly 11, 2026 | benzinga.comIperionX Limited (IPX) Latest Stock News & Headlines - Yahoo FinanceJuly 9, 2026 | finance.yahoo.comIperionX (ASX:IPX) After Camden Deal And Defense Award Is The Valuation Too RichJuly 9, 2026 | finance.yahoo.comSee More Headlines IPX Stock Analysis - Frequently Asked Questions How have IPX shares performed this year? IperionX's stock was trading at $36.19 on January 1st, 2026. Since then, IPX stock has decreased by 36.6% and is now trading at $22.94. Who are IperionX's major shareholders? IperionX's top institutional investors include GAMMA Investing LLC. Insiders that own company stock include Todd Hannigan and Anastasios Arima. View institutional ownership trends. How do I buy shares of IperionX? Shares of IPX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IperionX own? Based on aggregate information from My MarketBeat watchlists, some other companies that IperionX investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), e.l.f. Beauty (ELF), Jabil (JBL), Disc Medicine (IRON) and Builders FirstSource (BLDR). Company Calendar Today7/18/2026Next Earnings (Estimated)9/23/2026Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2w+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 For the last 2 weeks, IPX's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrials Industry Industrial Services Sub-IndustryNon-Metallic And Industrial Metal Mining Current SymbolNASDAQ:IPX CIK1898601 Webwww.iperionx.com Phone704 461 8000FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Price Target for IperionX$60.33 High Price Target$74.00 Low Price Target$52.00 Potential Upside/Downside+163.0%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.03 Current Ratio4.03 Quick Ratio4.00 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.89 per share Price / Book7.94Miscellaneous Outstanding Shares33,940,000Free FloatN/AMarket Cap$778.58 million OptionableNot Optionable Beta1.60 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:IPX) was last updated on 7/18/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredBuy this stock tomorrowMarc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership...Chaikin Analytics | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | Sponsored#1 Question to Ask Your Bank TodayElon Musk's new banking platform is paying up to 15 times the national average interest rate while insuring de...InvestorPlace | SponsoredPrint this and keep it by your screenEver been right about a stock's direction and still lost money on the trade? It's almost never bad luck - it's...Profits Run | SponsoredAI investors should get ready for a BIG surpriseWall Street insider Jason Bodner - who called Nvidia at $4.50 - says today's most popular AI stocks are about ...Brownstone Research | SponsoredURGENT Dollar Reset Warning for MondayA 50-year U.S.-Saudi arrangement established under Henry Kissinger - one credited with anchoring the dollar in...Golden Portfolio | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IperionX Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share IperionX With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.